Cambridge Investment Research Advisors »

Oncolytics Biotech shares owned by Cambridge Investment Research Advisors

Quarter-by-quarter ownership of Oncolytics Biotech (ONCY) shares owned by Cambridge Investment Research Advisors from 13F filings

Historical chart of Cambridge Investment Research Advisors investment in Oncolytics Biotech

Tip: Access up to 7 years of quarterly data

All positions including Oncolytics Biotech held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncolytics Biotech by Cambridge Investment Research Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $35k 25k 1.41
2025-06-30 $9.0k 11k 0.80

More positions owned by Cambridge Investment Research Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple Inc Com (AAPL)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corp Com (MSFT)
Amazon Com Inc Com (AMZN)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
SPDR S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Meta Platforms Inc Cl A (META)
Vanguard Index Fds Growth Etf (VUG)
Spdr Series Trust Portfolio S&P500 (SPLG)

View all positions for Cambridge Investment Research Advisors

Top funds holding Oncolytics Biotech

Citadel Advisors
Marshall Wace
Seeds Investor
Goldman Sachs Group
International Assets Investment Management
Franklin Resources
Royal Bank of Canada
Geode Capital Management
CIBC World Markets
LPL Financial
Headinvest
Badgley Phelps Wealth Managers
Bank Of Montreal
Ball & Co Wealth Management
SeaCrest Wealth Management

View all funds holding Oncolytics Biotech